The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by ...

(ii) Powder for Injection Tyclan Registration No 087923; each vial contains of Teicoplanin B.P 400mg batch number TL-011 manufactured by M/s MTI Medical (Pvt) Ltd, 586-587, Sundar Industrial ...